| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.37 | 0.2 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |